Alacizumab (Anti-VEGFR2 / KDR / CD309)

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.

• Supplier: Selleck Chemicals
• Product #: A3109
• Sku #: A3109-1mg